NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ROIV
2. HUVR:IN
3. NVS
4. TTE
5. ANET
6. NKE
7. BE
8. PANW
9. CL
10. SNDK

Go back to NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
(NASDAQ: NRXP) Delayed: 3.49 --0 (-0%)
Previous Close $3.49    52 Week High $ 
Open $3.49    52 Week Low $ 
Day High $3.49    P/E N/A 
Day Low $3.49    EPS $ 
Volume 667